Armando Orlandi/photos.asco.org
Mar 6, 2025, 10:57
Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Maurizio Callari, et al. on X:
“Cowabunga!
Riding Breast Cancer‘s Biggest Data’s Wave from Literature.
NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemo!
High TIL + low ER signaling = 72.7% pCR. TP53 mutations spell trouble though!
Targeting PAK4 for RD?”
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.
Authors: Maurizio Callari, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 3, 2025, 17:06
Apr 3, 2025, 16:56
Apr 3, 2025, 16:37
Apr 3, 2025, 16:04
Apr 3, 2025, 15:12